ES
Enavate Sciences Portfolio holdings
AUM
$177M
1 Year Est. Return
–
AUM
$177M
AUM Growth
+$43.8M
(+33%)
Holding
6
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunome
IMNM
$1.4B
| $44.3M | 25.12% |
4,768,583
|
|
||
|
SION
2
Sionna Therapeutics
SION
$1.69B
| $43M | 24.35% |
2,478,030
|
|
||
|
ZBIO
3
Zenas BioPharma
ZBIO
$1.47B
| $36.4M | 20.65% |
3,761,359
|
|
||
|
UPB
4
Upstream Bio Inc
UPB
$1.39B
| $27M | 15.3% |
2,459,703
|
|
||
5
Compass Therapeutics
CMPX
$642M
| $20.2M | 11.47% |
7,788,150
|
|
||
6
CAMP4 Therapeutics
CAMP
$83.9M
| $5.49M | 3.11% |
3,785,802
|
|